Compare Eaton Corporation plc (ETN) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Eaton Corporation plc trades at $398.91 (market cap $158.80B), while GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B). The key difference: Eaton Corporation plc is far larger — about 5.1× GE HealthCare Technologies Inc. Common Stock's market cap, and Eaton Corporation plc pays the higher dividend (1.08%). Which is the better fit depends on your goals.
| ETN | GEHC | |
|---|---|---|
Market Cap | $158.80B | $30.93B |
Volume | 3,207,896 | 5,033,451 |
Sector | Industrials | Health |
52-Week High | $459.96 | $88.16 |
52-Week Low | $315.82 | $59.48 |
Typical Hold Time | 32 Days | — |
Enterprise Value | $179.43B | $39.39B |
Dividend Yield | 1.08% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton (ETN) trades at $428.31, up 0.38% on the day, with a neutral technical signal and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Strong profitability is evident with a net income margin of 12.75% and ROE of 19.71%. Recent news highlights growth from data center and aerospace demand, supported by strategic acquisitions like COL Group (Business Wire, 2026-09-25).
The outlook remains positive given analyst consensus with a $502.38 price target and 70% buy ratings. Key opportunities include exposure to AI-driven data center expansion and grid modernization. Risks involve execution of acquisitions, competitive pressures, and macroeconomic sensitivity. Valuation multiples like a P/E of 43.62 suggest premium pricing relative to earnings growth.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
